Par Pharmaceutical Companies
Par Pharmaceutical Companies: annual report for the year ended Dec 31, 2008
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0000878088-09-000023
- Document
- 10-K
- Exhibit 10.6
- Terms of executive retention stock option award
- Exhibit 10.6
- Terms of 2009 restricted share award agreement
- Exhibit 10.6
- Terms of stock option agreement
- Exhibit 10.9
- Letter agreement and release
- Exhibit 10.9
- Employment agreement
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float not reported.
